The total return over the past 12 months is -73.82% vs. +16.94% for the S&P 500. So far it's up -84.02% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (73.70%) | (55.75%) | (76.77%) | (64.83%) | (58.87%) | (47.93%) |
| Total Return CAGR | (73.82%) | (55.84%) | (76.80%) | (64.85%) | (58.89%) | (47.94%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Tenax Therapeutics, Inc. (TENX)
| Year | Start price | End price | TENX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $12.19 | $1.96 | (84.02%) | +14.51% | (98.53%) |
| 2025 | $6.19 | $12.19 | +97.28% | +17.72% | +79.56% |
| 2024 | $21.97 | $6.19 | (71.87%) | +24.89% | (96.76%) |
| 2023 | $177.60 | $21.97 | (87.63%) | +26.19% | (113.82%) |
| 2022 | $1,664.00 | $177.60 | (89.33%) | (18.17%) | (71.16%) |
| 2021 | $2,976.00 | $1,664.00 | (44.09%) | +28.74% | (72.83%) |
| 2020 | $2,256.00 | $2,976.00 | +31.91% | +18.37% | +13.54% |
| 2019 | $1,936.00 | $2,256.00 | +16.53% | +31.22% | (14.69%) |
| 2018 | $15,680.00 | $1,936.00 | (87.65%) | (4.56%) | (83.09%) |
| 2017 | $62,400.00 | $15,680.00 | (74.87%) | +21.70% | (96.57%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
